Bio-Techne Corporation TECH 深 沪
已收盘 05-15 16:00:00 美东时间
43.30
-1.440
-3.22%
华盛通- 最 高45.59
- 今 开44.84
- 成交量 522.97万股
- 最 低 43.195
- 昨 收 44.74
- 总市值 67.74亿
- 52周最高 72.08
- 市盈率 静 94.27
- 换手率 3.34%
- 52周最低 43.195
- 委 比 82.37%
- 总股本 1.56亿
- 历史最高 134.5225
- 量 比 1.67
- 振 幅 5.35%
- 历史最低 11.6925
- 每 手 1
- 风险率 5.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RBC Capital Reinstates Outperform on Bio-Techne, Announces $62 Price Target
RBC Capital analyst Dan Leonard reinstates Bio-Techne (NASDAQ:TECH) with a Outperform and announces $62 price target.
05-15 21:21
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Evercore ISI Group Maintains In-Line on Bio-Techne, Lowers Price Target to $50
Evercore ISI Group analyst Daniel Markowitz maintains Bio-Techne (NASDAQ:TECH) with a In-Line and lowers the price target from $54 to $50.
05-07 23:03
财报速睇 | Bio-Techne Corporation 2026财年Q1营收3.11亿美元，同比下降1.5%；归母净利润0.51亿美元，同比增长125.9%
华盛资讯5月7日讯，Bio-Techne Corporation公布2026财年Q1业绩，公司Q1营收3.11亿美元，同比下降1.5%，归母净利润0.51亿美元，同比增长125.9%。
05-07 06:32
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.
05-07 01:35
Bio-Techne shares are trading lower after the company reported worse-than-expected Q3 financial results.
Bio-Techne shares are trading lower after the company reported worse-than-expec...
05-06 23:38
Bio-Techne Q3 2026 Earnings Call: Complete Transcript
Bio-Techne (NASDAQ:TECH) released third-quarter financial results and hosted an...
05-06 22:07
财报速睇 | Bio-Techne Corporation 2026财年Q1营收3.11亿美元，同比下降1.6%；归母净利润0.51亿美元，同比增长121.7%
华盛资讯5月6日讯，Bio-Techne Corporation公布2026财年Q1业绩，公司Q1营收3.11亿美元，同比下降1.6%，归母净利润0.51亿美元，同比增长121.7%。
05-06 19:13
Bio-Techne Q3 Adj. EPS $0.53 Misses $0.54 Estimate, Sales $311.415M Miss $317.093M Estimate
Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.54 by 1.85 percent. This is a 5.36 percent decrease over earnings of $0.56 per share from the same
05-06 18:32
